Competitive Landscape and Recent Industry Development Analysis 2020-2026 – PRnews Leader

Competitive Landscape and Recent Industry Development Analysis 2020-2026 – PRnews Leader

Original Source: Competitive Landscape and Recent Industry Development Analysis 2020-2026 – PRnews Leader

The Cannabidiol(CBD) Water market report explicit the complete details covering product definition, product type, and application. The report covers helpful subtleties which are sorted dependent on generation region, major players, and item type which will give a simplified view on the business. The Cannabidiol(CBD) Water market report shows the competitive scenario of the major market players dependent on the sales income, client requests, organization profile, the business tactics utilized in market which will help the emerging market segments in making vital business decisions.

The Cannabidiol(CBD) Water market research includes historic data from 2014 to 2020 and forecasts until 2025 which makes the report’s an invaluable resource for industry executives, Marketing, Sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Request Sample Report @ https://beathanreports.com/request-for-sample-report/12356

Breakdown Data by Type

Industrial Hemp-Derived

Medical Marijuana-Derived

Cannabidiol(CBD) Water Breakdown Data by Application

Supermarket

Online Retail

Offline Retail

Regional and Country-level Analysis

The Cannabidiol(CBD) Water market is analysed and market size information is provided by regions (countries).

The key regions covered in the Cannabidiol(CBD) Water market report are North America, Europe, South America and South Africa. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Cannabidiol(CBD) Water Market Share Analysis

Request Discount About This Report @ https://beathanreports.com/discount-request-on-report/12356 

Cannabidiol(CBD) Water Market Covers Following Points in TOC:

Chapter 1: Cannabidiol(CBD) Water Market Definition

Chapter 2: Research Methodology of Cannabidiol(CBD) Water Market

Chapter 3: Cannabidiol(CBD) Water Market Executive Summary

Chapter 4: Cannabidiol(CBD) Water Market Overview Includes Current Market Scenario, Porter’s Five Forces Analysis, Bargaining Power of Suppliers and Consumers, Threat of New Entrants and Substitute Product and Services

Chapter 5: Market Dynamics Covers Drivers, Restraints, Opportunities and Challenges

Chapter 6: Cannabidiol(CBD) Water Market Segmentation by Types, End-User, and Applications Forecast to 2024

Chapter 7: Cannabidiol(CBD) Water Market Segmentation by Geographical Regions

Chapter 8: Competitive Landscape of Cannabidiol(CBD) Water Market Includes Mergers & Acquisition Analysis, Agreements, Collaborations, and Partnerships, New Products Launches

Chapter 9: Key Players for Cannabidiol(CBD) Water Market

Have Any Query ask to our Expert @ https://beathanreports.com/get-expert-help/12356 

This article was republished on CBDNewsFeed.com from the original article, Competitive Landscape and Recent Industry Development Analysis 2020-2026 – PRnews Leader, which was originally published on 2020-10-14 15:15:00 (based on the date that was listed on the original article at the time it was republished). We shared this article on CBDNewsFeed.com because our editorial staff believed that its context was useful and helpful to our readers. If you have any questions regarding this article, please email us at .

Thank you for reading this article! We’d love to hear your thoughts and answer your questions in the comments below.

The UK Cannabis Industry Needs New PR Strategies

The cannabis marketplace is an ever changing one. The opportunities being generated in the UK space are immense. Yet despite the countless benefits cannabis can bring to the economy, patient care and supporting health and wellness for consumers, an image problem continues to persist.

Despite its expansive growth, there is still a lot of uncertainty and misinformation. Having worked with several cannabis businesses in recent years, I firmly believe there are a myriad of ways in which the industry can benefit from PR support. A strong PR strategy can not only drive media coverage, but help to reach customers, shorten sale cycles, bolster brand reputation and drive change within political and regulatory circles.

Whether you are a flourishing cannabis brand, a start-up or ancillary cannabis business, PR can help you stand out from the competition and become a credible voice in this competitive market.

Here are some key ways in which cannabis businesses can profit from PR:

Campaigning for progress

Each category of the cannabis sector faces its own reputational challenges. Medical cannabis is perhaps the most significant of these, yet it still goes largely misunderstood by the general public. This, along with regulatory restrictions and a lack of education in the clinical community means cannabis stigma continues to exist.

For the thousands of patients suffering with the likes of multiple sclerosis and epilepsy, still struggling to access this fully legal drug, this is a tragic, pressing issue. There are several families and individuals across the UK who campaign for medical cannabis access to be improved, by leveraging their story via the press and lobbying Parliament. Some of these high-profile families have been supported through strategic communications at The PHA Group, most notably Hannah Deacon, the mother who successfully campaigned for the first NHS cannabis license for her son, as well as the parents of toddler Charlie Hughes, who are currently seeking Judicial Review against NICE.

Both cases offer strong proof of the powerful role PR can play in supporting those in need of medical cannabis. Through speaking to media and generating coverage of the stories of both families, the complex issue of medical cannabis access has been thrust into the public eye, this in turn putting fresh pressure on the Government to address this through much-needed change. For cannabis leaders and professionals looking to invest in PR, it is critical that your PR partner understands the key issues, culture and complexities of the industry to create credible stories and campaigns to gain cut through in the media.

Reputation enhancement

CBD is the most established sector of the UK cannabis industry, having become firmly attached to the lifestyle scene in recent years with its broad spectrum of health and wellness products. With approximately 7.3 million people in the UK using CBD products each year through a market already worth an estimated £300 million, the industry is predicted to grow at a rapid rate, with experts claiming this figure will more than triple in the next five years.

Just some of the many hemp-derived CBD products on the market today.

Despite its impressive growth, the industry has faced its own stumbling blocks. Until this year, CBD had been in a period of regulatory uncertainty and the industry faced understandable criticism when high profile cannabis probes found over half of the most popular CBD oils did not contain the amount of CBD promised on the label. This did nothing to help the already precarious public perception of CBD in the UK, meaning firms have had to work extremely hard to heal their reputations and ensure their brands are deemed trustworthy by consumers going forward.

With hundreds of brands claiming to be the best option, establishing credibility and becoming a trusted voice is key. Educating your audience by positioning company experts will help to keep your audience up to speed on the most current information and allow your brand to achieve an authoritative voice within the cannabis space.

Amplifying awareness 

Driving awareness drives revenue. It doesn’t matter if your story and products are revolutionary if nobody knows they exist! PR can help build a narrative which conveys the purpose of your business, along with its vision and products, whilst promoting key insights to keep your company relevant. The power of public relations in this regard is very similar to that of positive word-of-mouth.

Strategic brand building

UKflagCannabis companies can’t advertise like mainstream companies, so they must tread carefully in the marketing of their products. However, there are great possibilities within PR. Through case studies and careful product placement, PRs can work carefully with CBD companies to raise awareness of the benefits of their products and solidify their brand image, without risking trouble with the ASA. With CBD brands and manufacturers springing up left and right, there are opportunities aplenty for PR firms to lend support, whether that’s from a consumer perspective, across food and drink, beauty or general wellness, or from a strategic business view.

Stories sell. It’s vital for a brand that wants to develop a sustainable, long-term plan to build a story which resonates with its audience. Strategic PR can therefore increase brand value and coupled with a digital marketing and social media strategy, boost engagement and elevate the profile of the business.

A wealth of opportunities

The legal cannabis industry is gaining traction and is one to watch. In relation to medical cannabis, the industry has called for change to improve patient access and pressure has been exerted on the government and regulatory bodies to normalise cannabis as an effective treatment for a myriad of health conditions In parallel, the CBD sector is only set to grow and in recent years, there has been increasing interest and investment into hemp, a versatile variety of the cannabis plant hailed as the next big thing in sustainability.

Cannabis is a commonplace yet spectacularly complex plant. It therefore needs a PR strategy which can uncover key angles and opportunities across a multitude of avenues to position brands within the space for success and growth.

Whilst there is still much to learn and navigate in cannabis, PR has an important role to play in changing attitudes as the industry continues to expand and evolve. I am excited to see where it goes next.

The post The UK Cannabis Industry Needs New PR Strategies appeared first on Cannabis Industry Journal.

CBD Skin Care Market Current Trend and Future Aspect Analysis and Impressively Grow in Future by 2027| – re:Jerusalem

CBD Skin Care Market Current Trend and Future Aspect Analysis and Impressively Grow in Future by 2027| – re:Jerusalem

Original Source: CBD Skin Care Market Current Trend and Future Aspect Analysis and Impressively Grow in Future by 2027| – re:Jerusalem

DBMR has added new report titled Global CBD Skin Care Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to know detailed analysis. CBD Skin Care marketing research report provides key analysis on the market status of the CBD Skin Care manufacturers with market size, growth, share, trends also as industry cost structure. The market type, organization size, availability on-premises, end-users’ organization type, and therefore the availability in areas like North America, South America, Europe, Asia-Pacific and Middle East & Africa are kept into focus while creating this global CBD Skin Care market report. the expansion of the CBD Skin Care market was mainly driven by the increasing R&D spending across the planet , however latest COVID scenario and economic slowdown have changed complete market dynamics.

CBD Skin Care marketing research report bestows clients with the simplest results and for an equivalent it’s been produced by using integrated approaches and therefore the latest technology. With this market report, it becomes easier to determine and optimize each stage within the lifecycle of an process that has engagement, acquisition, retention, and monetization. This market report gives a wide-ranging analysis of the market structure and therefore the evaluations of the varied segments and sub-segments of this industry. to not mention, several charts and graphs are used effectively within the CBD Skin Care report back to represent the facts and figures during a proper way.

Global CBD skin care Market is set to witness a healthy CAGR of 32.95% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing awareness about the benefits of CBD infused personal care products and rising self-consciousness among population are the factor for the market growth.

 Ask for Sample Copy of This Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cbd-skin-care-market    

Few of the major competitors currently working in the global CBD skin care market are Kiehl’s, Cannuka, LLC, Elixinol Global Limited, Medical Marijuana, Inc., ENDOCA., Lord Jones., VERTLYBALM., THE CBD SKINCARE CO., LEEF ORGANICS., JOSIE MARAN COSMETICS, CBD For Life, Kana Skincare, Apothecanna, KBLCOSMETICS., Pacific Roots, LLC., CBD Care Garden, LLC, FOLIUM BIOSCIENCES, Ecogen Labs, Nordic Oil., Satliva, among others.

Global CBD Skin Care Market By Source (Hemp, Marijuana), Type (Oil, Creams & Moisturizers, Masks & Serums, Cleansers, Others), Application (Mass Market, Smoke Shops, E-commerce, Others), Distribution (Online Sales, Offline Sales), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

 

 KNOW YOUR OPTIONS within the FIGHT AGAINST COVID-19
The COVID-19 Pandemic has created bottlenecks across industry pipelines, sales funnels, and provide chain activities. This has created unprecedented budget pressure on company spending for industry leaders. This has increased requirement for opportunity analysis, price trend knowledge and competitive outcomes. Use the DBMR team to make new sales channels and capture new markets previously unknown. DBMR helps its clients to grow in these uncertain markets.

Performs Competitive Analysis: The CBD Skin Care Market report incorporates the detailed analysis of the leading organizations and their thought process and what are the methodologies they are adopting to maintain their brand image in this market. The report aides the Food Fibers bees to understand the level of competition that they need to fight for to strengthen their roots in this competitive market.

Table of Contents: CBD Skin Care Market:
1 Introduction
2 Research Methodologies
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Compliance in CBD Skin Care Market
8 CBD Skin Care Market, By Service
9 CBD Skin Care Market, By Deployment Type
10 CBD Skin Care Market, By Organization Size
11 CBD Skin Care Market Analyses, By Vertical
12 Geographic Analyses

 And More…..Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-cbd-skin-care-market

 

 

 This CBD Skin Care Market Research/analysis Report Contains Answers to your following Questions:

• Which Manufacturing Technology is employed for CBD Skin Care?
• What Developments Are happening therein Technology?
• Which Trends Are Causing These Developments?
• Who Are the worldwide Key Players during this CBD Skin Care Market?
• What are Their Company Profile, Their Product Information, and get in touch with Information?
• What Was Global Market Status of CBD Skin Care Market?
• What Was Capacity, Production Value, Cost and PROFIT of CBD Skin Care Market?
• What Is Current Market Status of CBD Skin Care Industry?
• What’s Market Competition during this Industry, Both Company, and Country Wise?
• What’s marketing research of CBD Skin Care Market by Taking Applications and kinds in Consideration?
• What Are Projections of worldwide CBD Skin Care Industry Considering Capacity, Production and Production Value?
• What are going to be the Estimation of Cost and Profit?
• What are going to be Market Share, Supply and Consumption?

Benefits of shopping for The CBD Skin Care Market Report:

• A complete picture of the competitive scenario of CBD Skin Care market is depicted by this report.
• The report consists of a huge amount of knowledge about the recent product and technological developments within the markets.
• The extensive spectrum of study regarding the impact of those advancements on the longer term of market growth.
• The insights within the report are easy to know and include a graphical representation of the numbers within the sort of histograms, bar graphs, pie charts, etc.
• Components like market drivers, restraints, challenges, and opportunities for CBD Skin Care market are explained intimately .
• It also provides an entire assessment of the expected behaviour about the longer term market and changing market scenario.
• Making an informed business decision may be a tough job; this report offers several strategic business methodologies to support you in making those decisions.

Why Go For Data Bridge Market Research?

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others. We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: sales@databridgemarketresearch.com

 

 

This article was republished on CBDNewsFeed.com from the original article, CBD Skin Care Market Current Trend and Future Aspect Analysis and Impressively Grow in Future by 2027| – re:Jerusalem, which was originally published on 2020-10-12 21:03:06 (based on the date that was listed on the original article at the time it was republished). We shared this article on CBDNewsFeed.com because our editorial staff believed that its context was useful and helpful to our readers. If you have any questions regarding this article, please email us at .

Thank you for reading this article! We’d love to hear your thoughts and answer your questions in the comments below.

UT-Arlington and UT-El Paso to Evaluate Phytochrome Manipulation in Hemp

The Collaborative Laboratories for Environmental Analysis and Remediation (CLEAR) at the University of Texas at Arlington (UT-Arlington) and the University of Texas at El Paso (UT-El Paso) has begun collaborating with Curtis Mathes Grow Lights (CMGL), a subsidiary of the Curtis Mathes Corporation, and the hemp genetics company ZED Therapeutics. The research will involve characterizing the phytochemical effects of phytochrome manipulation using various LED horticultural lights of differing light spectrum, and novel high-yielding varietals of hemp. All of the hemp plants will be grown by renowned geneticists Adam Jacques, Christian West, and Oriah Love of ZED Therapeutics under the CMGL Harvester LED lights at their Oregon facility. Drs. Kevin Schug and Zacariah Hildenbrand will oversee the analysis of the corresponding samples for the expression of terpenes, flavonoids, and other classes of therapeutic compounds. The expression of 15 primary cannabinoid species will be performed concurrently by Matthew Spurlock of ZED Therapeutics.

“Since its inception, CLEAR has focused almost exclusively on improving environmental stewardship in the energy sector. It is nice to now diversify into the horticultural industry to better understand how chemically-diverse plants like hemp respond to different environmental-friendly LED lights,” says Professor Kevin Schug, Shimadzu Distinguished Professor of Analytical Chemistry and co-founder and the Director of CLEAR.

Hemp has recently garnered significant attention in the mainstream media as a result of the medicinal benefits of its primary natural constituent, CBD. The collaboration amongst UT-Arlington, UT-El Paso, CMGL and ZED Therapeutics is designed to better understand how the variable of light can influence the expression of other medicinal elements.

“We are incredibly excited about our growing collaborations with UT-Arlington, UT-El Paso, and ZED Therapeutics,” says CMGL’s COO, Robert Manes, “This particular research exploring phytochrome manipulation in hemp may unlock new lighting protocols whereby the modulation of different wavelengths is associated with the expression of different phytochemical profiles.”

This research also has the potential to discover novel molecules that may be present in the ZED Therapeutic hemp varietals using high-resolution exploratory instruments that are unique to the laboratories of CLEAR, such as Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-QTOF-MS).

“We are always searching for new ways to expand our genetic catalogue and it will be interesting to see what sort of effects light modulation have on cannabinoid, terpene, and flavonoid expression,” says Adam Jacques of ZED Therapeutics, “Phytochrome manipulation, and any resulting epigenetic effects, is a poorly understood principle of horticulture and we see a significant opportunity with this research to unearth new knowledge.”

“Hemp is a unique plant both in its light spectrum adaptation and the wide range of phytochemicals it can potentially produce,” says Christian West of ZED Therapeutics, “I’ve been waiting my whole career to be a part of this research and having the lighting knowledge of CMGL combined with the analytical power of UT-Arlington and UT-El Paso is priceless in expanding our understanding of the plant.”

The post UT-Arlington and UT-El Paso to Evaluate Phytochrome Manipulation in Hemp appeared first on Cannabis Industry Journal.

Using Spreadsheets as Your ERP? Your Supply Chain Could Take a Hit

The cannabis supply chain – from seed to sale – is rife with intricacies including regulations and compliance. It requires coordination from multiple vendors responsible for different aspects of the end product. And as the industry either grows or retracts, use of data is vital to right-size supply to demand, enhance operational efficiencies and boost cost effectiveness.

However, there’s an industry-wide, data-management vulnerability among many cannabis companies, and it’s this: many are using spreadsheets in different aspects of data collection, management and analysis. This becomes a shaky foundation on which to manage processes, especially for applications like quality management. And to be fair, it’s not just this industry, but arguably cannabusinesses have more on the line in light of the ever-changing regulatory environment.

Many cannabis companies have some systems in place for order processing, inventory management, production management and the like, but they often still use spreadsheets to fill the intelligence gaps among various systems that don’t talk to one another. Managing supplier quality often falls into one those gaps.

The Problem with Spreadsheets

Most businesspeople understand spreadsheets. They know how to build and use them. Spreadsheets are incredibly powerful tools that are used to run more business processes than perhaps any other software product in the world. When a cannabis business first starts out, spreadsheets offer an affordable data management capability. But there comes a time when the business will need a more sophisticated, end-to-end enterprise solution.

Consider a recent incident in which the use of spreadsheets went terribly wrong. The British Government recently misplaced nearly 16,000 COVID-19 test results due to an Excel spreadsheet error. As a result, potentially infectious people may not have been notified by contact tracers that they should self-quarantine.

Companies can outgrow spreadsheets quickly as their business grows

In the ERP space, spreadsheets have been an issue since the 90’s, but this recent incident serves as a reminder that an overreliance on spreadsheets is still alive and kicking. One of the problems is that spreadsheets are often pushed beyond their intended use. Microsoft Excel has become the software Swiss Army Knife. There’s a development environment inside the software, and the system is often used as a database, not just as a calculation engine.

Companies outgrow spreadsheets when the volume of data fields increase, multiple users need access to the data, iron-clad audit trails are needed and when processes become more complex.

There’s also a breaking point. Cannabis companies may enter a dangerous zone of “too many spreadsheets,” when data security and integrity are at risk. Interestingly enough, this also happens in large companies, as they often have a mish-mash of on-premises legacy systems, acquired systems and new cloud-based systems – and spreadsheets are then used as the data consolidation tool for all these applications.

Applicability to the Cannabis Supply Chain

Visibility into the cannabis supply chain requires detailed track and trace capabilities across many suppliers. Anything left out means guesswork and more opportunities for mistakes. In other words, cobbled-together spreadsheets are the last thing cannabis businesses should rely on. Aggregating data into a spreadsheet from various systems and paper-based processes invites errors and can result in insights that are weeks or months out of date. Worse yet, there’s no drilldown capability when questions arise and no easy roll-up of information for decision-making.

Modern cloud ERP software can integrate an entire supply chain with ease

When supply chain quality must be sustained, the role of a common and integrated cloud platform for quality and ERP cannot be understated. Such a platform can capture sales, operations, inventory and purchasing data, and also integrate with production and quality control. This makes your quality processes and data integral to ERP and eliminates the data fragmentation, control and auditability issues associated with spreadsheets. In addition, companies can leverage operational insights from data reporting and analytics to find areas where they can enhance productivity, optimize inventory, improve planning accuracy and build better forecasts.

Moving to the Cloud

Modern cloud ERP provides this type of seamless platform. It’s easier to implement and does not consume as many IT resources as traditional on-premise ERP systems. Better yet, the more recent versions of cloud ERP are built using low-code technology which enables business users to customize screens, modify workflow processes, build their own apps and embed AI without needing expensive IT consultants or waiting for busy IT staff.

In other words, the flexibility that’s been the lure of spreadsheets is now available in cloud ERP, but the system utilizes proverbial governance guardrails that keep business users from swerving off the road and completely wrecking the system. For example, templates for apps and workflows are provided as a starting point. Business rules and “drag and drop” customization capabilities offer guided options, clearly defining what can and cannot be changed.Rootstock will be presenting during the Cannabis Quality Virtual Conference episode, Supply Chain Quality, on October 27. Click here to learn more

And as a result, quality steps aren’t skipped; audit trails remain intact and data is protected with rock-solid security permissions and data backups. And unlike spreadsheets, new ERP systems are designed for multiple users and remote access via mobile devices. In short, with the latest generation of ERP, companies can leverage the best of both worlds – an end-to-end cloud platform that provides data integration across an organization’s operation and the flexibility and ease-of-use of spreadsheets.

Supply Chain Case in Point

One customer we worked with previously coordinated its supply chain via email and Excel spreadsheets. It cut and pasted requisitions into individual supplier spreadsheets and emailed those out, and it kept a master spreadsheet to keep track of all supplier performance. Team members had to sift through spreadsheet columns and rows to find information they needed.

Today with a cloud platform, the company built an online community so processes could be automated and conducted via real-time connection and communications. Another immediate benefit was the customized supply chain dashboard. All relevant data across their entire supply chain was displayed in one place and in a user-friendly manner.

The dashboard showed production forecasts over a certain period of time. The company could detect whether the supply chain was on track or having issues with certain suppliers. It could see planned requisitions and monitor them until fulfillment was complete. It could also monitor the performance of various suppliers, whether they had on-time deliveries or not – and trace back items received. The company essentially has a snapshot of the overall health of its supply chain and all the underlying activity.

Let’s face it. 2020 has been a difficult year, but perhaps it’s the year that companies finally forego spreadsheets and enlist an industrial-strength cloud platform.

The post Using Spreadsheets as Your ERP? Your Supply Chain Could Take a Hit appeared first on Cannabis Industry Journal.

Where Is Cannabis Reform Expected to Move by the End of 2020?

The COVID-19 pandemic has certainly impacted the cannabis industry, no matter where you are. However, the impact of a global virus outbreak and subsequent economic recession has had a mixed impact overall on the industry, and further against a backdrop where the entire conversation of reform is also now an international one.

While the big international decisions were slowed down deliberately, as a result of the pandemic, there is a clear indication almost everywhere that this might also have been taken to allow countries to catch up to the inevitable.

Even in the world of cannabis there is a level of diplomacy. The good news of course is that as a result, the topic of reform is now on official agendas, and those are now moving forward with an air of authority.

As a result, here is a look at some of the most significant events that will impact the discussion long after this fall.

The WHO Vote In December Is A Massive Global Benchmark

There is little indication that the global health organization will punt on their reclassification discussion in December. This starts with the fact that Germany, ever cognizant of things like health management leadership is moving ahead with its medical program, full steam ahead.

Further, there are indications all across Europe that the individual countries where cannabis reform has clearly landed are having an impact on their neighbors, if not a more global discussion. European countries like France are quietly announcing medical trials to begin before the end of the first quarter of next year. And Italy just added hemp to its official list of medical plants. Bureaucracies do not move unless they have to, and in this case, they are clearly in transit on the cannabis conversation well beyond the interdiction only phase.

The New Zealand Recreational Vote Is Also Highly Important

Whether the Kiwis actually take this ground-breaking recreational decision across the finish line is almost immaterial at this point. The ballot measure is being decided during a national election within a week and further set against another one (the U.S.) where it is clearly not on the agenda in the immediate future.

That said, of course if the measure does pass, and there is late breaking evidence to suggest that it might, the bar, beyond whatever the UN decides, will have clearly been set.

With recreational reform, New Zealand will also join the ranks of Canada and Uruguay when it comes to this issue. If not, Luxembourg will most likely take this spot at the end of next year if plans continue to unfold as so far promised in country.

Without it, the country will join the many who are implementing plans to integrate the drug into formal medical infrastructure, which is far from a “loss,” at any level. That said it is a sign that individual countries, rather than regional or international bodies, will lead on the issue of reform and will continue to, no matter what the WHO does.

Regional Reform Is Shaping Up In Europe

Beyond this, of course, there are also signs that the issue of cannabis access, no matter what bucket it is being lumped into, is headed for a showdown in Europe on a regional level that has never been seen before.

The state of the Spanish industry now has a date with the European Court of Human Rights at Strasbourg over basic access issues. If that is decided for the plaintiffs, it will mean that not only will Spain be forced to formalize its own cannabis laws, but so will countries across Europe.

What that will mean for nascent recreational reform is also unclear, but at minimum, it spells good news for those who want to participate in the industry in a new way, and with a non-profit model so far not given much official traction across Europe so far.

The post Where Is Cannabis Reform Expected to Move by the End of 2020? appeared first on Cannabis Industry Journal.

Do Varying Cannabis Laws Adequately Serve Patients, Businesses or Government?

Cannabis laws are changing at a rapid pace across all 50 states and around the world. Currently, Cannabis is legal in 11 states for adults over the age of 21, and legal for medical use in 33 states.

Across the nation, many states have been struggling to enact a viable medical and potential adult use cannabis system since Initiative 59 and the “Legalization of Marijuana for Medical Treatment Initiative of 1998.”

Unfortunately, the program has been continuously impacted by the federal government’s presence, first with the passage of the Barr Amendment by Congress overturning the early legalization progress and continuing to delay the onset of the first medical sale at a dispensary until 2013. The federal government continues to exert influence and control over the program expansion including adding Congressional riders on every proposed update including the latest “Safe Cannabis Sales Act of 2019.”

In Washington DC for example, 18 organizations including the National Cannabis Industry Association (NCIA), the ACLU and Law Enforcement Action Partnership petitioned the US House and Senate Financial Services Subcommittees to remove the rider given that “[the] Current law has interfered with the District’s efforts to regulate marijuana, which has impacted public safety. Without the ability to regulate marijuana sales, the grey market for marijuana flourishes despite the need and want of the District leadership and residents alike to establish a regulatory model.”

States with limited availability of medical cannabis, possession laws or with the ability to legally gift up to one ounce and the constant pressure by the federal government, the grey market has expanded with public safety and the safety of these pop-up businesses put at risk. The current state health and safety laws require a seed-to-sale tracking system and testing at independent labs for all medical cannabis, however the grey market consumers are afforded no such protection. The District of Columbia is unique in the US cannabis landscape as it grapples with the local government trying to provide clarity, safety and equity to a medical and adult use community, but it is hampered by what it can and cannot control through federal influence.

As the United States continues to recover from the effects of the COVID-19 pandemic, control and use of tax revenue will move to center stage in all these communities and the cannabis tax revenue will return to focus.

Cannabis tax revenue has shown a massive disparity between projection and reality. In 2018, California projected upwards of one billion dollars in cannabis tax revenue, but in reality was only able to recover a third of that amount. California in response continues to increase the excise tax and even proposed changes to taxes dependent on the amount of THC, creating new pressure on producers, in-part pushing some back into the grey market.

During the pandemic, Colorado enacted emergency rules to extend cannabis sales online. Allowing customers to pay for cannabis via the web and then pick up their purchases at the store. In a testament to what is considered a “critical businesses” the cannabis industry is given opportunity to expand during the pandemic, but still hampered by severely limited access to standard e-commerce options as credit card merchants still remain concerned that cannabis sales are illegal under US federal law. Alaska, Massachusetts, Michigan, Illinois and Oregon also allowed online sales and curbside pick-up, but remain limited in sales as federal banking and access to credit is limited as the Secure and Fair Enforcement (SAFE) Banking Act remains in limbo.

Overarching technologies such as DNA tracking that provide a clear indicator that the cannabis is produced and tested from legal sources, can be proven safe and protects local legal businesses’ products against out of market cannabis would provide such clarity.

As the country moves forward from the COVID-19 health crisis, all legal and safe ways to rapidly restart the economy will be needed, the cannabis economy will be no exception. We should be looking to this emerging market right now to help safely drive revenue and taxes into our states.

The post Do Varying Cannabis Laws Adequately Serve Patients, Businesses or Government? appeared first on Cannabis Industry Journal.

Cannabidiol Market to see Huge Growth by 2025

Cannabidiol

Original Source: Cannabidiol Market to see Huge Growth by 2025

Cannabidiol

Latest released the research study on Global Cannabidiol Market, offers a detailed overview of the factors influencing the global business scope. Cannabidiol Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Cannabidiol Market. The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers.

Top players in Global Cannabidiol Market are:
ENDOCA BV (Netherlands), CBD American Shaman (United States), Isodiol International Inc. (Canada), Medical Marijuana Inc. (United States), Aurora Cannabis Inc. (Canada), Cannoid LLC (United States) , Canopy Growth Corporation (Canada), CV Sciences, Inc. (United States), Elixinol LLC (United States), NuLeaf Naturals, LLC. (United States)

Free Sample Report + All Related Graphs & Charts (Including COVID19 Impact Analysis) @: https://www.advancemarketanalytics.com/sample-report/71964-global-cannabidiol-market-1

Analyst at AMA have conducted special survey and have connected with opinion leaders and Industry experts from various region to minutely understand impact on growth as well as local reforms to fight the situation. A special chapter in the study presents Impact Analysis of COVID-19 along with tables and graphs related to various country and segments showcasing impact on growth trends.

Brief Overview on Cannabidiol
Cannabidiol (CBD) is one of the hundreds of cannabinoids that are found in the cannabis plant. This is a naturally occurring substance, can be extracted & mixed with a carrier oil, often hemp seed or coconut, to create CBD oil. Cannabidiol oil can be derived from two different species of cannabinoids such as marijuana and hemp. Rising awareness about the health benefits of Cannabidiol is the major factors that are expected to drive the growth of the global Cannabidiol market. The demand for Cannabidiol is increasing around the globe owing to their capacity to cure various ailments in the human body. Cannabidiol in the form of CBD oil is used for the protection from Alzheimer’s disease and has anti-inflammatory properties. It also benefits in the treatment of epilepsy and mental health disorders. The adoption rate of Cannabidiol is increasing because they help in drug withdrawal. It is highly recommended, as it can suppress the growth of cancer cells to prevent cancer.

Cannabidiol Market Data Breakdown and Market Segmentation:
Study by Type (Marijuana-Derived Cannabidiol Products, Hemp-Derived Cannabidiol Products), Application (Personal Care & Cosmetics, Pharmaceutical (Anxiety, Fibromyalgia (FM), Diabetes and Other), Food & Beverages, Others), Sales Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, Others), Cultivation Type (Organic, Inorganic)

Market Drivers
• Growing Awareness Regarding Health benefits of CBD oil
• Globally Increasing Millennial Population and Rising E-Commerce Industry

Market Trend
• Increasing Legalization of Cannabis-Based Products
• Legalization of Cannabis for Medicinal and Recreational Activities

Market Challenges
• Lack of Harvesting Innovations and Processing Facilities
• Strict Government Regulations in Some Countries

Market Restraints:
• High Cost of the Product
• Availability of Low Yield

Avail 10-25% Discount on various license types @ https://www.advancemarketanalytics.com/request-discount/71964-global-cannabidiol-market-1

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Strategic Points Covered in Table of Content of Global Cannabidiol Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Global Cannabidiol market
Chapter 2: Exclusive Summary – the basic information of the Global Cannabidiol Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Global Cannabidiol
Chapter 4: Presenting the Global Cannabidiol Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region 2013-2020
Chapter 6: Evaluating the leading manufacturers of the Global Cannabidiol market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
Finally, Global Cannabidiol Market is a valuable source of guidance for individuals and companies.

Data Sources & Methodology
The primary sources involve the industry experts from the Global Cannabidiol Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.
In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company’s Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weightage.

Get More Information: https://www.advancemarketanalytics.com/reports/71964-global-cannabidiol-market-1

What benefits does AMA research study is going to provide?
• Latest industry influencing trends and development scenario
• Open up New Markets
• To Seize powerful market opportunities
• Key decision in planning and to further expand market share
• Identify Key Business Segments, Market proposition & Gap Analysis
• Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@advancemarketanalytics.com

Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies’ revenues.

This release was published on openPR.

This article was republished on CBDNewsFeed.com from the original article, Cannabidiol Market to see Huge Growth by 2025, which was originally published on 2020-10-12 12:15:00 (based on the date that was listed on the original article at the time it was republished). We shared this article on CBDNewsFeed.com because our editorial staff believed that its context was useful and helpful to our readers. If you have any questions regarding this article, please email us at .

Thank you for reading this article! We’d love to hear your thoughts and answer your questions in the comments below.

Former Denver Cannabis Regulator Joins Allay Consulting

Last week, Allay Consulting announced a new hire, a previous cannabis regulator for the city of Denver. Kara Lavaux has earned her Certified Professional-Food Safety (CP-FS) certification and supervised the Denver Department of Public Health & Environment’s cannabis program before joining Allay Consulting.

Kara Lavaux, Allay’s newest hire

“Demand is increasing for compliance assistance in the industry,” says Kim Stuck, CEO and founder of Allay Consulting. “Kara brings a robust background as a pioneer for cannabis public health regulations. With the hemp market gearing up for federal regulation, this was the ideal time to expand our team.”

“As one of the first Marijuana Specialists in the nation, I wanted to stay in the cannabis industry,” says Lavaux. “Joining the Allay team allows me to utilize my regulatory knowledge to support hemp and cannabis companies and help them thrive.”

Lavaux brings more than 14 years of experiences as a regulator in Colorado, with six years of experience overseeing the cannabis program.

The post Former Denver Cannabis Regulator Joins Allay Consulting appeared first on Cannabis Industry Journal.

Benefits, How It Works & Scientific Evidence

Benefits, How It Works & Scientific Evidence

Original Source: Benefits, How It Works & Scientific Evidence

Delta 8-THC is surging in popularity.

Delta 8-THC is not as well-known as Delta 9-THC, the main type of THC in cannabis. It’s also not as well-known as other cannabinoids like CBD and THC – but Delta 8-THC could provide its own powerful benefits.

As research on Delta 8-THC continues, we’re learning more about the cannabinoid and how it works.

What is Delta 8-THC? How does Delta 8-THC work? What’s the difference between it and Delta-9 THC or other cannabinoids? Find out everything you need to know about Delta 8-THC today in our review.

What is Delta 8-THC?

Delta 8-THC is a cannabinoid. Cannabinoids are natural chemicals found within the cannabis plant. Other well-known cannabinoids include tetrahydrocannabinol (THC) and cannabidiol (CBD).

THC and CBD gets lots of attention. They’re the two most-studied cannabinoids in the cannabis plant. However, there are hundreds of other cannabinoids in the plant, and research is increasingly linking those cannabinoids to various benefits.

Most tetrahydrocannabinol (THC) in the cannabis plant is Delta 9-THC. In fact, some use Delta 9-THC and THC interchangeably: most THC is Delta 9-THC, so they don’t bother to differentiate it. When cannabis products list their dosage of THC, they’re listing their dosage of Delta 9-THC.

THC – including Delta 9-THC – is the main psychoactive ingredient in the cannabis plant. It’s the compound that causes you to feel high.

Delta 8-THC also gets you high – but to a lesser extent than Delta 9-THC. Research shows Delta 8-THC could provide similar therapeutic benefits to Delta 9-THC – but without unwanted side effects.

The lack of psychoactive properties is important. In studies, researchers gave Delta 8-THC to children with cancer, for example, to reduce the risk of vomiting. In other studies, mice treated with Delta 8-THC increased appetite – all without unwanted side effects linked to ordinary THC.

Some claim Delta 8-THC gives them a more clear-headed high, allowing them to enjoy the benefits of CBD and the overall cannabis plant while still feeling productive and energized.

Why is Delta 8-THC a Big Deal?

Here’s the most important thing to know about Delta 8-THC: it appears to provide similar benefits to its well-known partner, Delta 9-THC, but with less intense side effects.

In other words, Delta-8 THC could help you enjoy the benefits of ordinary THC (like the feeling of being high) without the unwanted side effects (like paranoia and anxiety) caused by getting too high.

Like Delta 9-THC, Delta-8 THC binds to CB1 receptors. Unlike Delta 9-THC, however, Delta 8-THC is more stable and less potent. It has a lower affinity for CB1 receptors, which could be the reason for the lessened effect.

Why haven’t you heard of Delta 8-THC before?

Well, there’s relatively little Delta 8-THC in the cannabis plant. It’s not as common as Delta 9-THC, and it cannot be naturally found in large quantities in the plant. You must extract it from the plant or synthesize it.

Benefits of Delta 8-THC

As more studies get released, we’re learning more about Delta 8-THC and how it works.

In this report published through MedGen, researchers described Delta 8-THC as “an analogue of tetrahydrocannabinol (THC) with antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective properties.”

In non-medical terms, researchers linked Delta 8-THC to anti-nausea (antiemetic), anti-anxiety (anxiolytic), and pain relief (analgesic) benefits, among other effects. Delta 8-THC could stimulate your appetite. It could also protect brain cells thanks to its neuroprotective effects.

Researchers also found that Delta 8-THC “exhibits a lower psychotropic potency” than Delta 9-THC. It still gets you high, but you don’t get as high as you normally would taking the same amount of THC.

Early Delta 8-THC products on the market today are praised for their ability to deliver CBD-like benefits and a different type of “high” than ordinary THC.

Many users claim Delta 8-THC gives them a more clear-headed high, for example. Because Delta 8-THC is a form of THC, it still gets you high – but many people claim they don’t feel out of control. Some claim to feel energized and motivated after taking Delta 8-THC – not lethargic.

The most notable benefits linked to Delta 8-THC include:

  • Stimulate appetite
  • Help with pain and inflammation
  • Eliminate nausea in cancer patients
  • Enjoy a clearer-headed high compared to ordinary THC
  • Enjoy CBD-like benefits in terms of anxiety, pain, and inflammation
  • Could work topically (applied to the skin) or orally

Benefits, How It Works & Scientific Evidence | CBDNewsFeed

Scientific Evidence for Delta 8-THC

Delta 8-THC has only recently become legal in small quantities, which is why there’s been limited Delta 8-THC research up to this point.

This 1995 study described Delta 8-THC as “an efficient new cannabinoid” with “lower psychotropic potency than the main cannabis constituent, delta-9-THC.” In that study, researchers gave Delta 8-THC to children aged 3 to 13 years with hematologic cancers and found that Delta 8-THC reduced nausea related to cancer treatment. Researchers observed no significant side effects.

In 2004, researchers analyzed Delta 8-THC and its effect on appetite control. Researchers gave Delta 8-THC to mice who had recently completed a weight loss regimen. Researchers found that Delta 8-THC caused increased food consumption and improved cognitive function without the effects typically linked to cannabis.

Based on these results, researchers suggested that a low dose of Delta 8-THC “might be a potential therapeutic agent in the treatment of weight disorders.”

More recent studies have linked Delta 8-THC to other effects.

This 2018 study published in Cannabis and Cannabinoid Research found that Delta 8-THC could reduce pain and inflammation in mice. Researchers applied Delta 8-THC topically to mice and observed reduced pain and inflammation on the area. Researchers linked these benefits to Delta 8-THC’s effects on CB1 receptors.

Researchers observed similar pain-relief effects in another trial on rats. Researchers found that Delta 8-THC was linked to pain relief in rats, although they also found that rats quickly developed a tolerance to the cannabinoid.

Although these studies are promising, they’re also limited. There are few other major studies on Delta 8-THC. The studies above were performed on small groups of people or animal models.

With media attention on Delta 8-THC growing, however, expect to see more studies on the compound moving forward.

Delta 8-THC and the Entourage or Ensemble Effect

Some believe Delta 8-THC could encourage an entourage or ensemble effect.

The entourage or ensemble effect is the idea that cannabis works best when taking the full spectrum of cannabinoids at once. Instead of isolating a specific cannabinoid – like THC or CBD – you can enjoy more powerful effects by taking all cannabinoids at once.

Theoretically, Delta THC-8 should help with the entourage effect because it’s another cannabinoid. However, there’s no research proving that cannabis is more or less effective with Delta THC-8.

Is Delta 8-THC Legal?

There’s some confusion about the legality of Delta 8-THC.

Because Delta 8-THC is a version of THC, it’s not legal nationwide. Like THC, Delta 8-THC gets you high – even if it’s a lesser effect.

The 2018 Farm Bill clarified the legal status of non-psychoactive cannabis plants. That bill stated that hemp products were legal if they contained less than 0.3% THC. However, the bill specifically stated 0.3% of Delta 9-THC. It did not specify the amount of Delta 8-THC because it’s considered a minor cannabinoid.

Because of the lack of clarification, people assumed Delta 8-THC was legal in any concentration. Because Delta 8-THC was not specifically mentioned, people could start growing Delta 8-THC strains or synthetic versions of Delta 8-THC.

However, the DEA recently published an addendum to the 2018 Farm Bill clarifying the legal status of Delta 8-THC. The addendum redefines tetrahydrocannabinols under the law, stating that it’s illegal to synthetically produce THC in any form – regardless of whether it’s Delta 8-THC or Delta 9-THC:

“For synthetically derived tetrahydrocannabinols, the concentration of Δ 9-THC is not a determining factor in whether the material is a controlled substance. All synthetically derived tetrahydrocannabinols remain schedule I controlled substances.”

In other words, the DEA closed the loophole. The legal status of Delta 9-THC isn’t totally clear today. Some argue it should be treated like any version of THC, while others argue that Delta 9-THC is legal if extracted from hemp plants with less than 0.3% THC overall.

Get Ready for Delta 8-THC Extracts and Synthetics

One reason why Delta 8-THC is lesser known is because cannabis plants have naturally low concentrations of the cannabinoid.

Most cannabis plants are rich with Delta 9-THC, the well-known substance with psychoactive effects. Hemp, by law, contains less than 0.3% Delta 9-THC.

To access the benefits of Delta 8-THC, we need to extract it or synthesize it.

This is where manufacturers get confused: is Delta 8-THC legal if synthesized in lower concentrations than 0.3%? Can we synthesize or extract Delta 8-THC from hemp plants (which are legal nationwide) and turn them into high-concentration Delta 8-THC therapies?

These are questions the cannabis industry needs to answer about Delta 8-THC moving forward.

Benefits, How It Works & Scientific Evidence | CBDNewsFeed

Savage Enterprises Delta Effex

Despite murky regulations, one company is going ahead with its Delta 8-THC product. CBD and kratom company Savage Enterprises is entering the cannabis-derived products space with a product called Delta Effex.

Delta Effex contains Delta 8-THC – not the Delta 9-THC contained in most other cannabis and THC products. As mentioned above, Delta 8-THC could provide many of the therapeutic benefits of THC without the downsides.

In an interview with Merry Jane, Alfredo Gomez of Savage Enterprises described the benefits of Delta 8-THC and the potential for their product moving forward.

Gomez praised Delta 8-THC for being an isomer of CBD and a derivative of hemp and CBD, which makes Delta Effex legal nationwide: the product contains less than 0.3% Delta 9-THC, while the Delta 8-THC is like a “middle ground” between hemp, CBD, and Delta 9-THC.

Gomez claimed the Delta 8-THC in Delta Effex will still get you high, because Delta 8-THC is still a psychoactive compound. However, he claims many people enjoy “a more clear-headed high” compared to Delta 9-THC.

Some claim to get a surge in motivation and energy when taking Delta Effex in low dosages, according to Gomez. Many still get a euphoric sensation.

Delta Effex comes in the form of a cartridge. You add the cartridge to your battery device, then vape. The company also plans to launch a Delta 8-THC Pod and a Pod Device in the near future.

Who Should Use Delta 8-THC?

Delta 8-THC could fill the needs of a unique segment of the market.

According to Gomez, Delta Effex customers are people who use CBD but don’t like Delta 9-THC because it gets them too high. They want a middle ground that provides the benefits of CBD and a mild feeling of highness – without feeling like they have impaired their cognitive functions.

Delta THC-8 Safety & Side Effects

Because research on Delta THC-8 is limited, it’s hard to verify the safety and efficacy of the compound. Theoretically, the compound should have similar side effects to ordinary THC. However, we still don’t know much about Delta THC-8 and how it works – so it’s not clear how side effects could work.

This 1976 study linked Delta THC-8 and Delta THC-9 to increased blood pressure in rats. Researchers found that both forms of THC constricted blood vessels temporarily, which raised blood pressure. This rise in blood pressure was followed by a drop in blood pressure and a slower heart rate.

In this 2018 review, researchers analyzed over a dozen studies on Delta 8-THC to analyze its safety. Researchers found that Delta 8-THC raised heart rate and blood pressure in animals, although these effects were not observed in humans. Delta 8-THC raised heart rate in humans – but it did not raise blood pressure. Based on this analysis, researchers concluded that Delta 8-THC “acts differently according to species and experimental conditions.” They also found that “data is limited”, recommending further studies to verify the safety of the compound.

Meanwhile, the pain relief study on rats linked above found that rats quickly developed a tolerance to Delta 8-THC. Rats enjoyed significant pain relief, although they grew tolerant to it over time.

Overall, early research suggests that Delta 8-THC has similar side effects and safety to Delta 9-THC (the most common type of THC), although more research is needed (particularly on humans).

Final Word

Delta 8-THC products have officially hit the market.

Some take Delta 8-THC to enjoy the benefits of CBD with a better “high”. Some report experiencing a more clear-headed high, for example, than they would with ordinary THC products.

Early research suggests Delta 8-THC could have powerful benefits with pain, anxiety, and nausea. However, there’s limited research to date about the safety or efficacy of Delta 8-THC.

Stay tuned for more information about Delta 8-THC as research on the cannabinoid continues to grow.

This article was republished on CBDNewsFeed.com from the original article, Benefits, How It Works & Scientific Evidence, which was originally published on 2020-10-11 16:45:00 (based on the date that was listed on the original article at the time it was republished). We shared this article on CBDNewsFeed.com because our editorial staff believed that its context was useful and helpful to our readers. If you have any questions regarding this article, please email us at .

Thank you for reading this article! We’d love to hear your thoughts and answer your questions in the comments below.